Industry Updates for the Psychedelics World

Psychedelics News

Industry

29 Nov 2021

ATAI Increases Ownership in COMPASS Pathways

Atai Life Sciences, the psychedelic medicine industry’s leader by market cap, has announced the purchase of another 619,095 Compass Pathways shares....

By Jason Najum

Industry

26 Nov 2021

Seelos Raises $20M, Acquires Ketamine Tech, and Announces New Drug

This week Seelos released several pieces of important news: they raised $20 million in capital, acquired a worldwide license for sublingual ketamine delivery technology, and announced the evaluation of a...

By Jason Najum

Industry

25 Nov 2021

Industry Update: Funding For Psychedelic Startups Hits Record Levels

The psychedelic medicine market has been taking a beating as of late, but despite this short-term pain the overall outlook continues to be strong....

By Jason Najum

Industry

16 Nov 2021

Novamind Secures Psychedelic Insurance Coverage From Major Providers

Novamind is a company that “provides ketamine-assisted psychotherapy and other novel treatments through its network of Cedar Psychiatry clinics and operates Cedar Clinical Research” — and they’ve announced that Blue...

By Jason Najum

Join Our Newsletter for Exclusive Updates, Stories, and More

Industry

11 Nov 2021

First legal Psilocybin Mushroom group therapy treatment for nine end-of life-patients

My Community Journeys announced that they recently hosted the first legal group therapy session with psilocybin mushrooms ever in North America....

By Microdose

Industry

9 Nov 2021

Wonderland Day One: A huge success

We’ve been working on it for what seems like forever — and day one of Wonderland was a huge success....

By Microdose

Industry

9 Nov 2021

COMPASS Pathways Announces Positive Results From Groundbreaking Phase 2b Trial

The industry has been waiting for this....

By Jason Najum

Industry

8 Nov 2021

IMIO Partners With QuantaliX To Map Brain Network Response To Psychedelic Therapy

Press Release IMIO Partners With QuantaliX To Map Brain Network Response To Psychedelic Therapy The collaboration will apply QuantalX’s breakthrough device Delphi·MD™ technology to develop a comprehensive database relating to...

By Microdose

Industry

29 Oct 2021

Cybin Gets FDA Study Approval and Launches New Training Program

This week the company returned to our news feeds with two solid announcements....

By Jason Najum

Follow us on social

Latest News

AbbVie Withdraws Patent Challenge, Clearing Path for Enveric’s Psychedelic IP Strategy

Breaking: Enveric Reports New Mechanistic Data Supporting Non-Hallucinogenic Neuroplastogen Strategy

Two New Studies Are Rewriting the Rules of Psychedelic Drug Development

Professional Training in Psychedelic Medicine

Psychedelic medicine is reshaping the future of mental health care. From the power of microdosing LSD to the promise of MDMA in PTSD, the world of medical psychedelics offers transformative possibilities. Our comprehensive, CE-accredited course provides you with the knowledge and understanding you need to tap into this groundbreaking field.

WordPress Ads

No Result

View All Result